BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 18538736)

  • 21. Antiproliferative Effects of Epigenetic Modifier Drugs Through E-cadherin Up-regulation in Liver Cancer Cell Lines.
    Uribe D; Cardona A; Esposti DD; Cros MP; Cuenin C; Herceg Z; Camargo M; Cortés-Mancera FM
    Ann Hepatol; 2018; 17(3):444-460. PubMed ID: 29735783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A coactivator role of CARM1 in the dysregulation of β-catenin activity in colorectal cancer cell growth and gene expression.
    Ou CY; LaBonte MJ; Manegold PC; So AY; Ianculescu I; Gerke DS; Yamamoto KR; Ladner RD; Kahn M; Kim JH; Stallcup MR
    Mol Cancer Res; 2011 May; 9(5):660-70. PubMed ID: 21478268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma.
    Li J; Ying J; Fan Y; Wu L; Ying Y; Chan AT; Srivastava G; Tao Q
    Cancer Biol Ther; 2010 Sep; 10(6):617-24. PubMed ID: 20603606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disruption of the Dapper3 gene aggravates ureteral obstruction-mediated renal fibrosis by amplifying Wnt/β-catenin signaling.
    Xue H; Xiao Z; Zhang J; Wen J; Wang Y; Chang Z; Zhao J; Gao X; Du J; Chen YG
    J Biol Chem; 2013 May; 288(21):15006-14. PubMed ID: 23580654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy.
    El-Awady RA; Hersi F; Al-Tunaiji H; Saleh EM; Abdel-Wahab AH; Al Homssi A; Suhail M; El-Serafi A; Al-Tel T
    Cancer Biol Ther; 2015; 16(7):1056-70. PubMed ID: 25962089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
    Zhong S; Fields CR; Su N; Pan YX; Robertson KD
    Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer.
    Bian J; Dannappel M; Wan C; Firestein R
    Cells; 2020 Sep; 9(9):. PubMed ID: 32961708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mechanism of Wnt signaling pathway regulation by a truncated mutant of Axin2 in colorectal cancer].
    Wang FW; Wen L; Zhu SW; Yao Q; Cai YM; Ma G
    Ai Zheng; 2007 Oct; 26(10):1041-6. PubMed ID: 17927870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. All Trans-Retinoic Acid Mediates MED28/HMG Box-Containing Protein 1 (HBP1)/β-Catenin Signaling in Human Colorectal Cancer Cells.
    Lee MF; Hsieh NT; Huang CY; Li CI
    J Cell Physiol; 2016 Aug; 231(8):1796-803. PubMed ID: 26660958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of the tumor suppressor CYLD enhances Wnt/beta-catenin signaling through K63-linked ubiquitination of Dvl.
    Tauriello DV; Haegebarth A; Kuper I; Edelmann MJ; Henraat M; Canninga-van Dijk MR; Kessler BM; Clevers H; Maurice MM
    Mol Cell; 2010 Mar; 37(5):607-19. PubMed ID: 20227366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperglycemia impedes definitive endoderm differentiation of human embryonic stem cells by modulating histone methylation patterns.
    Chen ACH; Lee YL; Fong SW; Wong CCY; Ng EHY; Yeung WSB
    Cell Tissue Res; 2017 Jun; 368(3):563-578. PubMed ID: 28283910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyper-activation of WNT/β-catenin signaling pathway mediates anti-tumor effects of histone deacetylase inhibitors in acute T lymphoblastic leukemia.
    Shao N; Zou J; Li J; Chen F; Dai J; Qu X; Sun X; Ma D; Ji C
    Leuk Lymphoma; 2012 Sep; 53(9):1769-78. PubMed ID: 22303878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deregulation of Wnt/β-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumors.
    Kim JT; Li J; Jang ER; Gulhati P; Rychahou PG; Napier DL; Wang C; Weiss HL; Lee EY; Anthony L; Townsend CM; Liu C; Evers BM
    Carcinogenesis; 2013 May; 34(5):953-61. PubMed ID: 23354304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleoredoxin sustains Wnt/β-catenin signaling by retaining a pool of inactive dishevelled protein.
    Funato Y; Terabayashi T; Sakamoto R; Okuzaki D; Ichise H; Nojima H; Yoshida N; Miki H
    Curr Biol; 2010 Nov; 20(21):1945-52. PubMed ID: 20970343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wnt inhibitory factor-1 functions as a tumor suppressor through modulating Wnt/β-catenin signaling in neuroblastoma.
    Zhang J; Zhou B; Liu Y; Chen K; Bao P; Wang Y; Wang J; Zhou Z; Sun X; Li Y
    Cancer Lett; 2014 Jun; 348(1-2):12-9. PubMed ID: 24561119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prickle-1 negatively regulates Wnt/beta-catenin pathway by promoting Dishevelled ubiquitination/degradation in liver cancer.
    Chan DW; Chan CY; Yam JW; Ching YP; Ng IO
    Gastroenterology; 2006 Oct; 131(4):1218-27. PubMed ID: 17030191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.
    Quan H; Zhou F; Nie D; Chen Q; Cai X; Shan X; Zhou Z; Chen K; Huang A; Li S; Tang N
    Oncogene; 2014 May; 33(22):2826-35. PubMed ID: 23770846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FOXKs promote Wnt/β-catenin signaling by translocating DVL into the nucleus.
    Wang W; Li X; Lee M; Jun S; Aziz KE; Feng L; Tran MK; Li N; McCrea PD; Park JI; Chen J
    Dev Cell; 2015 Mar; 32(6):707-18. PubMed ID: 25805136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer.
    Kondo Y; Shen L; Issa JP
    Mol Cell Biol; 2003 Jan; 23(1):206-15. PubMed ID: 12482974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor.
    Mitsui Y; Yasumoto H; Nagami T; Hiraki M; Arichi N; Ishikawa N; Araki A; Maruyama R; Tanaka Y; Dahiya R; Shiina H
    Oncotarget; 2014 Apr; 5(8):2198-207. PubMed ID: 24755523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.